428 related articles for article (PubMed ID: 10322646)
1. Mechanisms of the therapeutic effect of astragalus membranaceus on sodium and water retention in experimental heart failure.
Ma J; Peng A; Lin S
Chin Med J (Engl); 1998 Jan; 111(1):17-23. PubMed ID: 10322646
[TBL] [Abstract][Full Text] [Related]
2. Messenger RNA expressions of vasopressin system and aquaporin-2 in adriamycin-induced nephrotic rats and effects of astragalus membranaceus.
Ma J; Fan S; Chen J; Gu Y; Lin S
Chin Med J (Engl); 1999 Dec; 112(12):1068-72. PubMed ID: 11721440
[TBL] [Abstract][Full Text] [Related]
3. Effects of nonpeptide vasopressin V2 antagonist tolvaptan in rats with heart failure.
Veeraveedu PT; Watanabe K; Ma M; Palaniyandi SS; Yamaguchi K; Suzuki K; Kodama M; Aizawa Y
Biochem Pharmacol; 2007 Nov; 74(10):1466-75. PubMed ID: 17720144
[TBL] [Abstract][Full Text] [Related]
4. Increased urinary aquaporin-2 excretion in response to furosemide in patients with chronic heart failure.
Starklint J; Bech JN; Nyvad O; Jensen P; Pedersen EB
Scand J Clin Lab Invest; 2006; 66(1):55-66. PubMed ID: 16464787
[TBL] [Abstract][Full Text] [Related]
5. Increased susceptibility to heart failure in response to volume overload in mice lacking natriuretic peptide receptor-A gene.
Nishikimi T; Hagaman JR; Takahashi N; Kim HS; Matsuoka H; Smithies O; Maeda N
Cardiovasc Res; 2005 Apr; 66(1):94-103. PubMed ID: 15769452
[TBL] [Abstract][Full Text] [Related]
6. Effects of novel vasopressin receptor antagonists on renal function and cardiac hypertrophy in rats with experimental congestive heart failure.
Bishara B; Shiekh H; Karram T; Rubinstein I; Azzam ZS; Abu-Saleh N; Nitecki S; Winaver J; Hoffman A; Abassi ZA
J Pharmacol Exp Ther; 2008 Aug; 326(2):414-22. PubMed ID: 18467593
[TBL] [Abstract][Full Text] [Related]
7. Role of neutral endopeptidase 24.11 in AV fistular rat model of heart failure.
Wegner M; Hirth-Dietrich C; Stasch JP
Cardiovasc Res; 1996 Jun; 31(6):891-8. PubMed ID: 8759244
[TBL] [Abstract][Full Text] [Related]
8. Glucocorticoids improve renal responsiveness to atrial natriuretic peptide by up-regulating natriuretic peptide receptor-A expression in the renal inner medullary collecting duct in decompensated heart failure.
Liu C; Chen Y; Kang Y; Ni Z; Xiu H; Guan J; Liu K
J Pharmacol Exp Ther; 2011 Oct; 339(1):203-9. PubMed ID: 21737535
[TBL] [Abstract][Full Text] [Related]
9. Regulation of renal sodium and water excretion in the nephrotic syndrome and cirrhosis of the liver.
Jespersen B
Dan Med Bull; 1997 Apr; 44(2):191-207. PubMed ID: 9151012
[TBL] [Abstract][Full Text] [Related]
10. Vasopressin release, water channels, and vasopressin antagonism in cardiac failure, cirrhosis, and pregnancy.
Schrier RW; Fassett RG; Ohara M; Martin PY
Proc Assoc Am Physicians; 1998; 110(5):407-11. PubMed ID: 9756091
[TBL] [Abstract][Full Text] [Related]
11. Captopril and ANP: changes in renal hemodynamics, glomerular-ANP receptors and guanylate cyclase activity in rats with heart failure.
Lee RW; Raya TE; Michael U; Foster S; Meeks T; Goldman S
J Pharmacol Exp Ther; 1992 Jan; 260(1):349-54. PubMed ID: 1346164
[TBL] [Abstract][Full Text] [Related]
12. Osmoregulation of natriuretic peptide receptors in bromoethylamine-treated rat kidney.
Yuan K; Jin X; Gao S; Shah A; Kim SY; Kim SZ; Kim SH
Peptides; 2009 Jun; 30(6):1137-43. PubMed ID: 19463747
[TBL] [Abstract][Full Text] [Related]
13. Effects of V2-receptor antagonist tolvaptan and the loop diuretic furosemide in rats with heart failure.
Veeraveedu PT; Watanabe K; Ma M; Palaniyandi SS; Yamaguchi K; Kodama M; Aizawa Y
Biochem Pharmacol; 2008 Mar; 75(6):1322-30. PubMed ID: 18179782
[TBL] [Abstract][Full Text] [Related]
14. Elevation of plasma atrial natriuretic peptide in rats with chronic heart failure by SCH 39370, a neutral metalloendopeptidase inhibitor.
Tikkanen I; Helin K; Tikkanen T; Sybertz EJ; Vemulapalli S; Sariola H; Näveri H; Fyhrquist F
J Pharmacol Exp Ther; 1990 Aug; 254(2):641-5. PubMed ID: 2143536
[TBL] [Abstract][Full Text] [Related]
15. Intravenous administration of conivaptan hydrochloride improves cardiac hemodynamics in rats with myocardial infarction-induced congestive heart failure.
Wada K; Fujimori A; Matsukawa U; Arai Y; Sudoh K; Yatsu T; Sasamata M; Miyata K
Eur J Pharmacol; 2005 Jan; 507(1-3):145-51. PubMed ID: 15659304
[TBL] [Abstract][Full Text] [Related]
16. Chronic administration of phosphodiesterase type 5 inhibitor suppresses renal production of endothelin-1 in dogs with congestive heart failure.
Yamamoto T; Wada A; Ohnishi M; Tsutamoto T; Fujii M; Matsumoto T; Takayama T; Wang X; Kurokawa K; Kinoshita M
Clin Sci (Lond); 2002 Aug; 103 Suppl 48():258S-262S. PubMed ID: 12193099
[TBL] [Abstract][Full Text] [Related]
17. [Effects of shenqifuxin oral liquid on the plasma kaliuretic peptide, the myocardial contractility and relaxation of left ventricle and the left ventricular remodeling in experimental rats with heart failure].
Ma L; Lei Y; Xue Q; Wang SW; Yang DY; Lu ZZ
Zhongguo Zhong Yao Za Zhi; 2003 Jul; 28(7):656-60. PubMed ID: 15139115
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of natriuretic peptides and their receptors in volume overload cardiac hypertrophy in the rat.
Su X; Brower G; Janicki JS; Chen YF; Oparil S; Dell'Italia LJ
J Mol Cell Cardiol; 1999 Oct; 31(10):1927-36. PubMed ID: 10525429
[TBL] [Abstract][Full Text] [Related]
19. Possible vascular role of increased plasma arginine vasopressin in congestive heart failure.
Nakamura T; Funayama H; Yoshimura A; Tsuruya Y; Saito M; Kawakami M; Ishikawa SE
Int J Cardiol; 2006 Jan; 106(2):191-5. PubMed ID: 16321691
[TBL] [Abstract][Full Text] [Related]
20. Attenuated diuretic and natriuretic effects of atrial natriuretic peptide in rats with heart failure.
Tikkanen T; Tikkanen I; Sariola H; Svartström-Fraser M; Fyhrquist F
Horm Metab Res; 1989 Apr; 21(4):185-8. PubMed ID: 2526789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
